Net Cash Provided by (Used in) Investing Activities of CITIUS ONCOLOGY, INC. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
CITIUS ONCOLOGY, INC. quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • CITIUS ONCOLOGY, INC. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Dec 2025 was $4,400,000.
  • CITIUS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Investing Activities for 2025 was $5,750,000, a 15% decline from 2024.
  • CITIUS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $5,000,000, a 279% decline from 2023.
  • CITIUS ONCOLOGY, INC. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $1,320,000, a 98% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

CITIUS ONCOLOGY, INC. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,400,000 01 Oct 2025 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q1 2024 $24,738,789 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024 2024 Q1

CITIUS ONCOLOGY, INC. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,750,000 -$750,000 -15% 01 Oct 2024 30 Sep 2025 10-K 23 Dec 2025 2025 FY
2024 $5,000,000 -$3,680,000 -279% 01 Oct 2023 30 Sep 2024 10-K 23 Dec 2025 2025 FY
2023 $1,320,000 +$66,000,000 +98% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
2022 $67,320,000 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.